MGTA Annual Shareholders Equity
$105.96 M
-$66.71 M-38.64%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual stockholders equity is $105.96 million, with the most recent change of -$66.71 million (-38.64%) on December 31, 2022. During the last 3 years, it has fallen by -$35.23 million (-24.96%).MGTA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Shareholders Equity
$74.60 M
-$2.85 M-3.69%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly stockholders equity is $74.60 million, with the most recent change of -$2.85 million (-3.69%) on June 30, 2023. Over the past year, it has dropped by -$61.07 million (-45.01%).MGTA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.6% | -45.0% |
| 3 y3 years | -25.0% | -57.1% |
| 5 y5 years | +110.6% | -56.7% |
MGTA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -38.6% | -63.2% |
Magenta Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $74.60 M(-3.7%) |
| Mar 2023 | - | $77.46 M(-26.9%) |
| Dec 2022 | $105.96 M(-38.6%) | $105.96 M(-14.6%) |
| Sept 2022 | - | $124.03 M(-8.6%) |
| June 2022 | - | $135.68 M(-10.3%) |
| Mar 2022 | - | $151.19 M(-12.4%) |
| Dec 2021 | $172.67 M(+20.0%) | $172.67 M(-9.0%) |
| Sept 2021 | - | $189.69 M(-6.5%) |
| June 2021 | - | $202.89 M(+57.2%) |
| Mar 2021 | - | $129.06 M(-10.3%) |
| Dec 2020 | $143.91 M | $143.91 M(-9.2%) |
| Sept 2020 | - | $158.57 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $173.91 M(+38.7%) |
| Mar 2020 | - | $125.40 M(-11.2%) |
| Dec 2019 | $141.19 M(-3.1%) | $141.19 M(-12.6%) |
| Sept 2019 | - | $161.53 M(-10.0%) |
| June 2019 | - | $179.56 M(+34.0%) |
| Mar 2019 | - | $134.00 M(-8.0%) |
| Dec 2018 | $145.65 M(+189.4%) | $145.65 M(-8.8%) |
| Sept 2018 | - | $159.78 M(-7.2%) |
| June 2018 | - | $172.22 M(+324.3%) |
| Mar 2018 | - | $40.59 M(-19.3%) |
| Dec 2017 | $50.32 M(+456.5%) | $50.32 M |
| Dec 2016 | $9.04 M | - |
FAQ
- What is Magenta Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Magenta Therapeutics?
- What is Magenta Therapeutics annual shareholders equity year-on-year change?
- What is Magenta Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly shareholders equity year-on-year change?
What is Magenta Therapeutics annual stockholders equity?
The current annual shareholders equity of MGTA is $105.96 M
What is the all time high annual shareholders equity for Magenta Therapeutics?
Magenta Therapeutics all-time high annual stockholders equity is $172.67 M
What is Magenta Therapeutics annual shareholders equity year-on-year change?
Over the past year, MGTA annual stockholders equity has changed by -$66.71 M (-38.64%)
What is Magenta Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MGTA is $74.60 M
What is the all time high quarterly shareholders equity for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly stockholders equity is $202.89 M
What is Magenta Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MGTA quarterly stockholders equity has changed by -$61.07 M (-45.01%)